CHRA Earnings & Forecasts - Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,633.62+0.16%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

CHRA

CHRANasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

CHRA Earnings & Forecasts - Benzinga

CHRA Earnings & Forecasts

CHRA (CHRA) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

CHRA Guidance

Recent Earnings Results

Metric	Q3 '22	Q2 '22	Q1 '22	Q4 '21
Earnings Per Share (Non-GAAP)
Estimate	$-3.10	$-2.10	$-1.90	$0.60
Actual	$-4.30	$-3.40	$-4.20	$-0.20
Surprise	-38.7%	-61.9%	-121.0%	-133.3%
Revenue
Estimate	$80.5M	$79.5M	$66.1M	$84.1M
Actual	$81.5M	$77.1M	$66.1M	$93.4M
Surprise	+1.32%	-2.98%	-0.03%	+11.1%

Earnings & Guidance News

Charah Solutions's Return On Capital Employed Overview

Benzinga Insights

PRO
Charah Solutions Q3 EPS $(0.43) Misses $(0.31) Estimate, Sales $81.54M Beat $80.48M Estimate

Benzinga Newsdesk

Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Benzinga Insights

Charah Solns: Q2 Earnings Insights

Charah Solns (NYSE:CHRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga Insights

Charah Solutions Lowers FY22 Revenue Guidance From $325M-$365M To $310M-$340M Vs $343.11M Est., Lowers Adj. EBITDA Guidance From $35M-$40M To $25M-$30M

Michael Horton

Charah Solutions Q2 Adj. EPS $(0.34) Misses $(0.21) Estimate, Sales $77.11M Miss $79.48M Estimate

Charah Solutions (NYSE:CHRA) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.21) by 61.9 percent. This is a 70 percent decrease over losses of $(0.20) per share from the

Michael Horton

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	Nov 14, 2022	$-4.30	$-3.10	-38.7 %
Q2	Aug 15, 2022	$-3.40	$-2.10	-61.9 %
Q1	May 10, 2022	$-4.20	$-1.90	-121.0 %
Q4	Mar 31, 2022	$-0.20	$0.60	-133.3 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Nov 14, 2022	$81.54M	$80.48M	1.32 %
Q2	Aug 15, 2022	$77.11M	$79.48M	-2.98 %
Q1	May 10, 2022	$66.05M	$66.07M	-0.03 %
Q4	Mar 31, 2022	$93.43M	$84.11M	11.1 %